 | • レポートコード：MRC2312MG00574 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、65ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のオキシトシス薬品市場規模と予測を収録しています。・世界のオキシトシス薬品市場：売上、2018年-2023年、2024年-2029年 ・世界のオキシトシス薬品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のオキシトシス薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「オキシトシン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 オキシトシス薬品のグローバル主要企業は、Teva、 Abbott、 JHP Pharmaceuticals、 Novartis、 Baxter、 Pfizer、 Fresenius Kabi、 Ferring、 Dr. Reddy’s Laboratories、 Granules Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、オキシトシス薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のオキシトシス薬品市場：タイプ別、2018年-2023年、2024年-2029年 世界のオキシトシス薬品市場：タイプ別市場シェア、2022年 ・オキシトシン、麦角アルカロイド、プロスタグランジン、カルベトシン 世界のオキシトシス薬品市場：用途別、2018年-2023年、2024年-2029年 世界のオキシトシス薬品市場：用途別市場シェア、2022年 ・病院、専門クリニック、その他 世界のオキシトシス薬品市場：地域・国別、2018年-2023年、2024年-2029年 世界のオキシトシス薬品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるオキシトシス薬品のグローバル売上、2018年-2023年 ・主要企業におけるオキシトシス薬品のグローバル売上シェア、2022年 ・主要企業におけるオキシトシス薬品のグローバル販売量、2018年-2023年 ・主要企業におけるオキシトシス薬品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Teva、 Abbott、 JHP Pharmaceuticals、 Novartis、 Baxter、 Pfizer、 Fresenius Kabi、 Ferring、 Dr. Reddy’s Laboratories、 Granules Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 オキシトシス薬品市場の定義 市場セグメント 世界のオキシトシス薬品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のオキシトシス薬品市場規模 世界のオキシトシス薬品市場規模：2022年 VS 2029年 世界のオキシトシス薬品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのオキシトシス薬品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のオキシトシス薬品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：オキシトシン、麦角アルカロイド、プロスタグランジン、カルベトシン オキシトシス薬品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、専門クリニック、その他 オキシトシス薬品の用途別グローバル売上・予測 ・地域別市場分析 地域別オキシトシス薬品市場規模 2022年と2029年 地域別オキシトシス薬品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Teva、 Abbott、 JHP Pharmaceuticals、 Novartis、 Baxter、 Pfizer、 Fresenius Kabi、 Ferring、 Dr. Reddy’s Laboratories、 Granules Pharmaceuticals ... |
This research report provides a comprehensive analysis of the Oxytocic Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oxytocic Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oxytocic Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Oxytocic Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oxytocic Medicine market presents opportunities for various stakeholders, including Hospitals, Specialized Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oxytocic Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Oxytocic Medicine market was valued at US$ 148.1 million in 2022 and is projected to reach US$ 220.8 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Oxytocic Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oxytocic Medicine market.
Market Overview: The report provides a comprehensive overview of the Oxytocic Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oxytocin, Ergot Alkaloids), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oxytocic Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oxytocic Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oxytocic Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Oxytocic Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oxytocic Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oxytocic Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oxytocic Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oxytocic Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Oxytocic Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oxytocin
Ergot Alkaloids
Prostaglandins
Carbetocin
Market segment by Application
Hospitals
Specialized Clinics
Other
Global Oxytocic Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Teva
Abbott
JHP Pharmaceuticals
Novartis
Baxter
Pfizer
Fresenius Kabi
Ferring
Dr. Reddy’s Laboratories
Granules Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oxytocic Medicine, market overview.
Chapter 2: Global Oxytocic Medicine market size in revenue.
Chapter 3: Detailed analysis of Oxytocic Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxytocic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Oxytocic Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oxytocic Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oxytocic Medicine Overall Market Size
2.1 Global Oxytocic Medicine Market Size: 2022 VS 2029
2.2 Global Oxytocic Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oxytocic Medicine Players in Global Market
3.2 Top Global Oxytocic Medicine Companies Ranked by Revenue
3.3 Global Oxytocic Medicine Revenue by Companies
3.4 Top 3 and Top 5 Oxytocic Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oxytocic Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oxytocic Medicine Players in Global Market
3.6.1 List of Global Tier 1 Oxytocic Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Oxytocic Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Oxytocic Medicine Market Size Markets, 2022 & 2029
4.1.2 Oxytocin
4.1.3 Ergot Alkaloids
4.1.4 Prostaglandins
4.1.5 Carbetocin
4.2 By Type – Global Oxytocic Medicine Revenue & Forecasts
4.2.1 By Type – Global Oxytocic Medicine Revenue, 2018-2023
4.2.2 By Type – Global Oxytocic Medicine Revenue, 2024-2029
4.2.3 By Type – Global Oxytocic Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oxytocic Medicine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialized Clinics
5.1.4 Other
5.2 By Application – Global Oxytocic Medicine Revenue & Forecasts
5.2.1 By Application – Global Oxytocic Medicine Revenue, 2018-2023
5.2.2 By Application – Global Oxytocic Medicine Revenue, 2024-2029
5.2.3 By Application – Global Oxytocic Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Oxytocic Medicine Market Size, 2022 & 2029
6.2 By Region – Global Oxytocic Medicine Revenue & Forecasts
6.2.1 By Region – Global Oxytocic Medicine Revenue, 2018-2023
6.2.2 By Region – Global Oxytocic Medicine Revenue, 2024-2029
6.2.3 By Region – Global Oxytocic Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Oxytocic Medicine Revenue, 2018-2029
6.3.2 US Oxytocic Medicine Market Size, 2018-2029
6.3.3 Canada Oxytocic Medicine Market Size, 2018-2029
6.3.4 Mexico Oxytocic Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Oxytocic Medicine Revenue, 2018-2029
6.4.2 Germany Oxytocic Medicine Market Size, 2018-2029
6.4.3 France Oxytocic Medicine Market Size, 2018-2029
6.4.4 U.K. Oxytocic Medicine Market Size, 2018-2029
6.4.5 Italy Oxytocic Medicine Market Size, 2018-2029
6.4.6 Russia Oxytocic Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Oxytocic Medicine Market Size, 2018-2029
6.4.8 Benelux Oxytocic Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Oxytocic Medicine Revenue, 2018-2029
6.5.2 China Oxytocic Medicine Market Size, 2018-2029
6.5.3 Japan Oxytocic Medicine Market Size, 2018-2029
6.5.4 South Korea Oxytocic Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Oxytocic Medicine Market Size, 2018-2029
6.5.6 India Oxytocic Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Oxytocic Medicine Revenue, 2018-2029
6.6.2 Brazil Oxytocic Medicine Market Size, 2018-2029
6.6.3 Argentina Oxytocic Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Oxytocic Medicine Revenue, 2018-2029
6.7.2 Turkey Oxytocic Medicine Market Size, 2018-2029
6.7.3 Israel Oxytocic Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Oxytocic Medicine Market Size, 2018-2029
6.7.5 UAE Oxytocic Medicine Market Size, 2018-2029
7 Oxytocic Medicine Companies Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Oxytocic Medicine Major Product Offerings
7.1.4 Teva Oxytocic Medicine Revenue in Global Market (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Oxytocic Medicine Major Product Offerings
7.2.4 Abbott Oxytocic Medicine Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 JHP Pharmaceuticals
7.3.1 JHP Pharmaceuticals Company Summary
7.3.2 JHP Pharmaceuticals Business Overview
7.3.3 JHP Pharmaceuticals Oxytocic Medicine Major Product Offerings
7.3.4 JHP Pharmaceuticals Oxytocic Medicine Revenue in Global Market (2018-2023)
7.3.5 JHP Pharmaceuticals Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Oxytocic Medicine Major Product Offerings
7.4.4 Novartis Oxytocic Medicine Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Baxter
7.5.1 Baxter Company Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Oxytocic Medicine Major Product Offerings
7.5.4 Baxter Oxytocic Medicine Revenue in Global Market (2018-2023)
7.5.5 Baxter Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Oxytocic Medicine Major Product Offerings
7.6.4 Pfizer Oxytocic Medicine Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Fresenius Kabi
7.7.1 Fresenius Kabi Company Summary
7.7.2 Fresenius Kabi Business Overview
7.7.3 Fresenius Kabi Oxytocic Medicine Major Product Offerings
7.7.4 Fresenius Kabi Oxytocic Medicine Revenue in Global Market (2018-2023)
7.7.5 Fresenius Kabi Key News & Latest Developments
7.8 Ferring
7.8.1 Ferring Company Summary
7.8.2 Ferring Business Overview
7.8.3 Ferring Oxytocic Medicine Major Product Offerings
7.8.4 Ferring Oxytocic Medicine Revenue in Global Market (2018-2023)
7.8.5 Ferring Key News & Latest Developments
7.9 Dr. Reddy’s Laboratories
7.9.1 Dr. Reddy’s Laboratories Company Summary
7.9.2 Dr. Reddy’s Laboratories Business Overview
7.9.3 Dr. Reddy’s Laboratories Oxytocic Medicine Major Product Offerings
7.9.4 Dr. Reddy’s Laboratories Oxytocic Medicine Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.10 Granules Pharmaceuticals
7.10.1 Granules Pharmaceuticals Company Summary
7.10.2 Granules Pharmaceuticals Business Overview
7.10.3 Granules Pharmaceuticals Oxytocic Medicine Major Product Offerings
7.10.4 Granules Pharmaceuticals Oxytocic Medicine Revenue in Global Market (2018-2023)
7.10.5 Granules Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer